Pharmaceutical Marketing and the Marketing Management Process Flashcards
(23 cards)
A process through which market for
the pharmaceutical core is actualized.
Pharmaceutical Marketing
imports products from its
regional production hub and gets the service of local
manufacturer for packing/repacking/labelling.
Multinational importer
simply manufactures for a trader using
the trader’s own formulation.
Toll manufacturer
formulates its own products,
procures own materials, conducts R&D for formulation,
and manufactures for itself and for other partner traders.
Manufacturer-formulator
imports finished products in bulk,
then conducts re-packing/re-labelling.
Importer/repacker
centralizes supply chain data but faces hurdles like fragmented
procurement and inadequate cold storage for biologics.
electronic Logistics Management Information System (eLMIS)
oversees
licensing and accreditation of pharmaceutical
establishments, pre-marketing assessment and marketing
authorization, and post marketing surveillance including
pharmacovigilance, inspections of pharmaceutical
establishments, quality monitoring of marketed products
and monitoring of pharmaceutical claims and promotion.
Center for Drug Regulation & Research (CDRR)
is an authorization issued by the FDA
to an establishment to grant permission to undertake a trade or
carry out a business activity, such as manufacturing, importation,
exportation, sale, offering for sale, distribution, or transfer of food
products.
License to Operate (LTO)
an authorization
issued by FDA upon the approval of an application to register a
health product prior to engaging in marketing, importation,
exportation, sale, offer for sale, distribution, promotion,
advertisement, and/or sponsorship thereof.
Certificate of Product Registration (CPR)
regulates the manufacture,
importation, sale, promotion and advertising of health products,
including pharmaceuticals and medical devices.
FDA Act of 2009 (RA 9711)
promote, require, and ensure
the production of adequate distribution, use and acceptance of
drugs and medicines identified by their generic names.
Generics Act of 1988 (RA 6675)
to promote interests of
consumers through the promotion of public health and safety
measures and prevention of deceptive and unfair acts of
unscrupulous businessmen.
Consumer Act of 1991 (RA 7394)
to protect public health by promoting and
ensuring access to quality affordable medicines.
Universally Accessible and Affordable Quality Medicines Act
of 2008 (RA 9502)
issued by the DOH or the
Implementing Guidelines on the Promotion and Marketing of
Prescription Pharmaceutical Products and Medical Devices
(PPPMD Guidelines) provides detailed rules and guidelines on
advertising and promotion.
Administrative Order 2015-0053
The government has been encouraging foreign
pharmaceutical companies to establish manufacturing
facilities through the _______ act that will give tax
incentives to pharmaceutical firms with facilities there.
Corporate Recovery and Tax
Incentives for Enterprises (CREATE)
interconnected systems and
processes that bring drugs
from the lab to they e
patient.
Pharmaceutical markets
Evaluating the total sales revenue or volume of products sold
within the pharmaceutical industry or a specific segment to
understand the market’s scope and a company’s position
relative to competitors.
Market size and Share
Analyzing historical data and trends to forecast future
market growth, considering factors like the introduction of
new drugs, patent expirations, and changes in healthcare
policies.
Growth Rates
Assessing the quantity of drugs sold, which helps in
understanding the demand for various pharmaceutical
products and identifying high-performing drugs or
therapeutic areas.
Sales Volume
Studying the pricing strategies and trends for different
drugs, which is crucial in the pharmaceutical industry due to
the impact of regulatory decisions, insurance coverage, and
competitive dynamics.
Pricing Analysis
Measuring the investment in research and development as a
percentage of sales revenue, which is a critical factor for
innovation and long-term competitiveness in the
pharmaceutical industry.
Research and Development Expenditure
Monitoring patent filings and expirations to gauge the
innovation landscape and anticipate shifts in market
dominance as generic drugs enter the market following
patent expirations.
Patent Analysis
